INSPIRED Symposium Part 4A: Access to CAR T cell Therapy in Unique Populations with B-Cell Acute Lymphoblastic Leukemia

It is important to prospectively study patient-reported outcomes given the differential toxicity expected between CD19 CAR T cell therapy and the historic standard of care, hematopoietic cell transplant.